Delivery Order SPE2DE24DA010-SPE2D625F3NVK
- Not listed
- Abbott Laboratories Inc., through its Abbott Vascular Inc. division, has been awarded a fixed-price delivery order valued at $5,695.00 by the Medical Supply Chain division of the Department of Defense. The contract, awarded on May 30, 2025, with an ultimate completion date of June 4, 2025, represents a delivery order under a larger indefinite delivery vehicle. This award was made through full and open competition with no set-aside designation. The place of performance is Santa Clara, California....
- Abbott Laboratories Inc., through its Abbott Vascular Inc. division, has been awarded a fixed-price delivery order valued at $5,695.00 by the Defense Logistics Agency's Medical Supply Chain division. The contract, issued on May 20, 2025, with an ultimate completion date of June 9, 2025, represents a child contract under Abbott Laboratories Inc.'s parent entity and will be performed in Santa Clara, California. This delivery order was awarded without a set-aside designation, indicating full and...
- Abbott Laboratories Inc., through its Abbott Vascular Inc. division, was awarded a delivery order contract valued at $51.3K by the Medical Supply Chain, a defense-focused federal agency, on July 16, 2025. This fixed-price delivery order with economic price adjustment carries an ultimate completion date of July 21, 2025, and will be performed in Santa Clara, California. The contract was awarded under full and open competition with no set-aside designation, indicating Abbott competed against other...
- Abbott Laboratories Inc., through its Abbott Vascular Inc. division, was awarded a fixed-price delivery order (Contract No. 4568634478, GALLANT) by the Medical Supply Chain division of the Department of Defense on June 20, 2025, with an ultimate completion date of June 25, 2025. The contract, valued at $30,281.95, carries no set-aside designation, indicating full and open competition. Performance will occur at Abbott's facility in Santa Clara, California. This delivery order represents a...
- Abbott Laboratories Inc., through its Abbott Vascular Inc. division, has been awarded a fixed-price delivery order valued at $9,752.00 by the Department of Defense's Medical Supply Chain division for MRI-related medical supplies. The contract, issued on June 16, 2025, with an ultimate completion date of June 20, 2025, represents a delivery order under a broader procurement vehicle rather than a standalone award. The work will be performed in Santa Clara, California. This award is issued...
- Abbott Laboratories Inc., through its Abbott Vascular Inc. division, was awarded a fixed-price delivery order valued at $25,715.85 by the Defense Logistics Agency's Medical Supply Chain on August 12, 2025, with an ultimate completion date of August 21, 2025. The contract, identified as GALLANT (4569142750), will be performed in Santa Clara, California, and represents a non-set-aside award made through full and open competition. Abbott Vascular specializes in advanced cardiovascular medical...
- Abbott Laboratories Inc., through its Abbott Vascular Inc. division, was awarded a fixed-price delivery order valued at $25,715.85 by the Defense Logistics Agency's Medical Supply Chain on September 5, 2025, with an ultimate completion date of September 15, 2025. The contract, which carries no set-aside designation and reflects full and open competition, is for delivery to Santa Clara, California. This delivery order represents a task order against Abbott's existing Indefinite Delivery...
- Abbott Laboratories Inc., through its Abbott Vascular Inc. division, was awarded a $7,477.00 fixed-price delivery order (Contract No. 4569438355) for MRI-related products or services by the Defense Logistics Agency's Medical Supply Chain on September 8, 2025, with an ultimate completion date of September 11, 2025. The award was made on a full and open competition basis with no set-aside designation. The place of performance is Santa Clara, California. This delivery order represents a...
- Abbott Laboratories Inc., through its Abbott Vascular Inc. division, was awarded a fixed-price delivery order valued at $60,563.90 by the Defense Logistics Agency's Medical Supply Chain on September 16, 2025, with an ultimate completion date of September 19, 2025. The contract, designated as GALLANT (Contract Number 4569469210), was awarded without a set-aside designation, indicating full and open competition. The place of performance is located in Santa Clara, California. This delivery order...
- Abbott Laboratories Inc., through its Abbott Vascular Inc. division, was awarded a fixed-price delivery order valued at $28,350.00 by the Defense Logistics Agency's Medical Supply Chain on August 18, 2025, with an ultimate completion date of August 21, 2025. The contract, identified as AVEIR (a reference to Abbott's Aveir Leadless Pacemaker technology), will be performed in Santa Clara, California, and was awarded without a set-aside designation, indicating full and open competition. This...
- SPE2DE24DA010Indefinite Delivery Contract
- SPE2DE24DA010-SPE2D625F3NVKDelivery Order
Abbott Laboratories Inc., through its Abbott Vascular Inc. division, has been awarded a delivery order valued at $22,780.00 by the Medical Supply Chain division of the Department of Defense. This fixed-price delivery order with economic price adjustment was issued on September 16, 2025, with an ultimate completion date of September 19, 2025, and will be performed in Santa Clara, California. The award was made under full and open competition with no set-aside designation. The delivery order represents a continuation of Abbott Vascular's established role as a critical supplier of advanced cardiovascular medical technologies to federal defense and healthcare agencies. Abbott Vascular has secured a substantial $117.1 million Indefinite Delivery Contract with the Defense Logistics Agency's Medical Supply Chain for comprehensive procedural packages covering cardiovascular devices, instrumentation, and accessories, of which this delivery order is likely an individual task order. This award reflects the company's extensive capabilities in providing specialized medical devices and related services to support federal healthcare operations.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $22.8k | 9/16/25 |